日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapy

FEN1抑制剂在癌症治疗中单药治疗和联合治疗潜力的机制研究

Eeson Rajendra,Claudio A Lademann,Bethany Mason,Balca R Mardin,Lucy Armstrong,Silvia Peripolli,Julian Kreis,Timothea Konstantinou,Ulrich Pehl,Joerg Bomke,Stefanie Scharrelmann,David Perera,Birgitta Leuthner,Maria Filipa Pinto,Owen A Davis,Alessandro Galbiati,Ana Toste Rêgo,Claire L McWhirter,Elias Elinati,Ada Sala-Hojman,Julien Lefranc,Sam E Mann,Robert A Heald,Frank T Zenke,Graeme C M Smith,Helen M R Robinson,Lars T Burgdorf

Two-dimensional analysis of plasma-derived extracellular vesicles to determine the HER2 status in breast cancer patients.

利用二维分析血浆来源的细胞外囊泡来确定乳腺癌患者的 HER2 状态

Wilhelm Alexis, Flynn Charlotte, Hammer Evelyn, Roessler Johannes, Haller Bernhard, Napieralski Rudolf, Leuthner Moritz, Tosheska Sanja, Knoops Kèvin, Mathew Anjusha, Ciarimboli Giuliano, Kranich Jan, Flaskamp Lavinia, King Siobhan, Gevensleben Heidrun, Emslander Quirin, Pastucha Anna, Reisbeck Mathias, Rief Lukas, Bronger Holger, Dreyer Tobias, Bausch Andreas R, Pichlmair Andreas, Brocker Thomas, Zeidler Reinhard, Hammerschmidt Wolfgang, Piedavent-Salomom Melanie, López-Iglesias Carmen, Schricker Gabrielle, Haydn Oliver, Kiechle Marion, Grill Sabine, Heeren Ron, Knolle Percy A, Wilhelm Olaf, Höchst Bastian

M4205 (IDRX-42) Is a Highly Selective and Potent Inhibitor of Relevant Oncogenic Driver and Resistance Variants of KIT in Cancer.

M4205 (IDRX-42) 是一种对癌症中 KIT 相关致癌驱动因子和耐药变体具有高度选择性和强效抑制作用的抑制剂

Esdar Christina, Linde Nina, Blum Andreas, Schieferstein Hanno, Drechsler Christine, Sherbetjian Eva, Petersson Carl, Ross Edith, Leuthner Birgitta, Grädler Ulrich, Dorsch Dieter, Blaukat Andree

Effect of fathers in Preemie Prep for Parents (P3) program on couple's preterm birth preparedness

父亲参与“早产儿父母准备计划”(P3)对夫妇早产准备的影响

Basir, Mir A; McDonnell, Siobhan M; Brazauskas, Ruta; Kim, U Olivia; Ahamed, S Iqbal; McIntosh, Jennifer J; Pizur-Barnekow, Kris; Pitt, Michael B; Kruper, Abbey; Leuthner, Steven R; Flynn, Kathryn E

"Ringleader who has no power": a qualitative study of parent uncertainty during a NICU admission unrelated to prematurity

“无权无势的领头人”:一项关于新生儿重症监护室(NICU)入院期间父母不确定性的定性研究(与早产无关)

Rholl, Erin; Leuthner, Steven R; Malin, Kathryn J; Lagatta, Joanne; Olson, Krisjon R

Variability of Care Practices for Extremely Early Deliveries

极早产儿护理实践的差异

LoRe, Danielle; Groden, Catherine M; Schuh, Allison R; Holmes, Chondraah; Ostilla, Lorena; Vogel, Maggie M; Murray, Peter D; Yamasato, Kelly; Tonismae, Tiffany; Anani, Uchenna E; Henner, Natalia; Famuyide, Mobolaji; Leuthner, Steven R; Laventhal, Naomi; Andrews, Bree Landis; Tucker Edmonds, Brownsyne M; Brennan, Kathleen G; Feltman, Dalia M

Discovery of potent allosteric antibodies inhibiting EGFR

发现抑制 EGFR 的强效变构抗体

Léxane Fournier, Lukas Pekar, Birgitta Leuthner, Harald Kolmar, Lars Toleikis, Stefan Becker

Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models

新型甲硫氨酸氨肽酶2抑制剂M8891与VEGF受体抑制剂协同作用抑制肾细胞癌模型的肿瘤生长

Manja Friese-Hamim ,Maria J Ortiz Ruiz # ,Olga Bogatyrova # ,Marina Keil # ,Felix Rohdich ,Beatrix Blume ,Birgitta Leuthner ,Frank Czauderna ,Diane Hahn ,Julia Jabs ,Frank Jaehrling ,Timo Heinrich ,Roland Kellner ,Katherine Chan ,Amy H Y Tong ,Dirk Wienke ,Jason Moffat ,Andree Blaukat ,Frank T Zenke

Structure-specific variation in per- and polyfluoroalkyl substances toxicity among genetically diverse Caenorhabditis elegans strains

遗传多样的秀丽隐杆线虫菌株中全氟和多氟烷基物质毒性的结构特异性变化

Tess C Leuthner, Sharon Zhang, Brendan F Kohrn, Heather M Stapleton, L Ryan Baugh

Towards a Point-of-Care Test of CD4+ T Lymphocyte Concentrations for Immune Status Monitoring with Magnetic Flow Cytometry

使用磁流式细胞术进行 CD4+ T 淋巴细胞浓度即时检测以监测免疫状态

Moritz Leuthner, Mathias Reisbeck, Michael Helou, Oliver Hayden